Deep Dive Into Alphatec Holdings Stock: Analyst Perspectives (5 Ratings)
Analysts' ratings for Alphatec Holdings (NASDAQ:ATEC) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 1 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 2 | 0 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $23.6, a high estimate of $27.00, and a low estimate of $20.00. This current average reflects an increase of 1.51% from the previous average price target of $23.25.
Decoding Analyst Ratings: A Detailed Look
The standing of Alphatec Holdings among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Thomas Stephan | Stifel | Lowers | Buy | $20.00 | $24.00 |
| David Saxon | Needham | Maintains | Buy | $22.00 | $22.00 |
| Sean Lee | HC Wainwright & Co. | Maintains | Buy | $24.00 | $24.00 |
| Matt Miksic | Barclays | Raises | Overweight | $27.00 | $23.00 |
| Keith Hinton | Freedom Capital Markets | Announces | Buy | $25.00 | - |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Alphatec Holdings. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Alphatec Holdings compared to the broader market.
- Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Alphatec Holdings's stock. This comparison reveals trends in analysts' expectations over time.
To gain a panoramic view of Alphatec Holdings's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Alphatec Holdings analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Discovering Alphatec Holdings: A Closer Look
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
Alphatec Holdings: Delving into Financials
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Positive Revenue Trend: Examining Alphatec Holdings's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 30.38% as of 30 September, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Alphatec Holdings's net margin is impressive, surpassing industry averages. With a net margin of -14.54%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Alphatec Holdings's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -162.02%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Alphatec Holdings's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -3.62%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Alphatec Holdings's debt-to-equity ratio stands notably higher than the industry average, reaching 51.38. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
Analyst Ratings: What Are They?
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.